跳至主要内容
临床试验/NL-OMON42168
NL-OMON42168尚未招募2 期

Protein intake, gastro-Intestinal tolerance and safety after administration of a new high protein tube feed in critically ill overweight ICU patients as compared to an isocaloric standard tube feed. - PROTI

utricia0 个研究点目标入组 22 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
22

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age * 18 years.
  • 2. ICU stay and indication for tube feed via nasogastric tube.
  • 3. Expected to require study product for at least 5 days on the ICU
  • 4. BMI >= 25.0 kg/m2

排除标准

  • - Requiring other specific tube feed for medical reason.
  • - Having any contra-indication to receive tube feed such as severe shock, presence of partial or complete mechanical bowel obstruction, or intestinal ischemia or infarction.
  • - Abnormalities in GI tract which may impact GI function, such as short bowel syndrome - defined as entire length of small bowel totaling 122 centimeters or less-, Ulcerative Colitis or Crohn*s disease or any form of enterostomy.
  • - GI tract, abdominal or bariatric surgery within 72 hours before start intake study product or expected in the next 5 days after start study product intake.
  • - History of chronic pancreatitis or acute pancreatitis
  • - Expected to need parenteral feeding.
  • - Expected to need protein supplementation other than study product
  • - SOFA score >12 from admission to the ICU until 24 hours after admission or until randomisation in case of randomisation before 24 hours after admission

研究者

发起方
utricia

相似试验